InvaGen Pharmaceuticals, Inc.
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to InvaGen Pharmaceuticals, Inc.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| ATXI | Sale | 388,888 | $7.71 | $2,998,326 | Oct 11, 2022 |